Free Trial

ClearPoint Neuro Q1 2023 Earnings Report

ClearPoint Neuro logo
$15.55 +0.89 (+6.07%)
(As of 12/20/2024 05:40 PM ET)

ClearPoint Neuro EPS Results

Actual EPS
-$0.23
Consensus EPS
-$0.18
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

ClearPoint Neuro Revenue Results

Actual Revenue
$5.43 million
Expected Revenue
$5.21 million
Beat/Miss
Beat by +$220.00 thousand
YoY Revenue Growth
N/A

ClearPoint Neuro Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

ClearPoint Neuro Earnings Headlines

ClearPoint: Fundamentals Continue To Improve
ClearPoint Neuro (CLPT) Receives a Buy from Lake Street
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
ClearPoint Neuro announces SmartFlow Neuro Cannula FDA authorization
ClearPoint Neuro: Near-Term Volatility Is No Concern
See More ClearPoint Neuro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email.

About ClearPoint Neuro

ClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

View ClearPoint Neuro Profile

More Earnings Resources from MarketBeat

Upcoming Earnings